{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:00:29Z","timestamp":1766516429963,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.radonc.2022.11.012","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:53:09Z","timestamp":1669211589000},"page":"109423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Post-irradiation sarcoma after definitive radiation therapy for nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"178","author":[{"given":"Wan-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Huai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ku-Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Fan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Kuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.11.012_b0005","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68:394-424.","DOI":"10.3322\/caac.21492"},{"key":"10.1016\/j.radonc.2022.11.012_b0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","article-title":"Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"51","author":"Zhang","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.12.004","article-title":"Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study)","volume":"77","author":"Au","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0025","doi-asserted-by":"crossref","unstructured":"Huang TL, Chien CY, Tsai WL, Liao KC, Chou SY, Lin HC, et al. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. Head & neck. 2016;38:E1026-32.","DOI":"10.1002\/hed.24150"},{"key":"10.1016\/j.radonc.2022.11.012_b0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"102","author":"McDowell","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.012_b0035","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1097-0142(19940515)73:10<2653::AID-CNCR2820731030>3.0.CO;2-G","article-title":"A single-institution study and review of the literature","volume":"73","author":"Mark","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.11.012_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/wjon996w","article-title":"Radiation-induced malignancies making radiotherapy a \u201ctwo-edged sword\u201d: a review of literature","volume":"8","author":"Singh","year":"2017","journal-title":"World J Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0045","doi-asserted-by":"crossref","unstructured":"Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012;104:286-93.","DOI":"10.1016\/j.radonc.2012.08.013"},{"key":"10.1016\/j.radonc.2022.11.012_b0050","doi-asserted-by":"crossref","unstructured":"Du T, Xiao J, Qiu Z, Wu K. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. PloS one. 2019;14:e0219611.","DOI":"10.1371\/journal.pone.0219611"},{"key":"10.1016\/j.radonc.2022.11.012_b0055","doi-asserted-by":"crossref","unstructured":"Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. European journal of cancer (Oxford, England : 1990). 2015;51:2587-95.","DOI":"10.1016\/j.ejca.2015.08.006"},{"key":"10.1016\/j.radonc.2022.11.012_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2016.12.008","article-title":"Radiation-induced clustered DNA lesions: repair and mutagenesis","volume":"107","author":"Sage","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.radonc.2022.11.012_b0065","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's Lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.11.012_b0070","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2022.11.012_b0075","doi-asserted-by":"crossref","unstructured":"De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27:4239-46.","DOI":"10.1200\/JCO.2008.19.9174"},{"key":"10.1016\/j.radonc.2022.11.012_b0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(05)70387-9","article-title":"Lung cancer after treatment for Hodgkin's lymphoma: a systematic review","volume":"6","author":"Lorigan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0085","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2022.11.012_b0090","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1259\/bjr\/20938070","article-title":"Imaging findings of radiation-induced sarcoma of the head and neck","volume":"80","author":"Makimoto","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2022.11.012_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11547-016-0695-5","article-title":"Radiation-induced sarcomas of the head and neck in post-radiation nasopharyngeal carcinoma","volume":"122","author":"Yang","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.radonc.2022.11.012_b0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fonc.2018.00449","article-title":"Radiation-induced sarcoma of the head and neck: a review of the literature","volume":"8","author":"Giannini","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0105","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1002\/cncr.25329","article-title":"Radiation-induced sarcoma in patients with nasopharyngeal carcinoma: a single-institution study","volume":"116","author":"Xi","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.11.012_b0110","article-title":"Radiation-induced sarcoma of the head and neck following radiotherapy for nasopharyngeal carcinoma: a single institutional experience and literature review","volume":"10","author":"Lou","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0115","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/lary.23282","article-title":"Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma","volume":"122","author":"Chan","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2022.11.012_b0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12032-011-9828-9","article-title":"Radiation-induced sarcoma of head and neck: 50 years of experience at a single institution in an endemic area of nasopharyngeal carcinoma in China","volume":"29","author":"Wei","year":"2012","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"10.1016\/j.radonc.2022.11.012_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.joms.2015.07.013","article-title":"Clinical characteristics of radiation-induced sarcoma of the head and neck: review of 15 cases and 323 cases in the literature","volume":"74","author":"Zhu","year":"2016","journal-title":"J Oral Maxillofac Surg : Off J Am Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.radonc.2022.11.012_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-004-2472-8","article-title":"Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment","volume":"89","author":"Rubino","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2022.11.012_b0135","doi-asserted-by":"crossref","unstructured":"Berrington de Gonzalez A, Kutsenko A, Rajaraman P. Sarcoma risk after radiation exposure. Clinical sarcoma research. 2012;2:18.","DOI":"10.1186\/2045-3329-2-18"},{"key":"10.1016\/j.radonc.2022.11.012_b0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.012_b0145","doi-asserted-by":"crossref","unstructured":"D\u00f6rr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 2002;178:357-62.","DOI":"10.1007\/s00066-002-0951-6"},{"key":"10.1016\/j.radonc.2022.11.012_b0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00066-010-2050-4","article-title":"Second malignancies in high-dose areas of previous tumor radiotherapy","volume":"186","author":"Welte","year":"2010","journal-title":"Strahlentherapie und Onkol : Organ Deutschen Rontgengesellschaft [et al]"},{"key":"10.1016\/j.radonc.2022.11.012_b0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.icrp.2012.06.013","article-title":"Radiation biology and radiation protection","volume":"41","author":"Hendry","year":"2012","journal-title":"Ann ICRP"},{"key":"10.1016\/j.radonc.2022.11.012_b0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2022.04.004","article-title":"Treatment related factors associated with the risk of breast radio-induced-sarcoma","volume":"171","author":"Mirjolet","year":"2022","journal-title":"Radiother Oncol : J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0165","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1245\/s10434-013-2979-5","article-title":"Outcomes and prognostic factors of post-irradiation and de novo sarcomas of the head and neck: a histologically matched case-control study","volume":"20","author":"Yeang","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0170","doi-asserted-by":"crossref","unstructured":"Rosko AJ, Birkeland AC, Chinn SB, Shuman AG, Prince ME, Patel RM, et al. Survival and Margin Status in Head and Neck Radiation-Induced Sarcomas and De Novo Sarcomas. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017;157:252-9","DOI":"10.1177\/0194599817700389"},{"key":"10.1016\/j.radonc.2022.11.012_b0175","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1200\/JCO.2009.25.1728","article-title":"Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?","volume":"28","author":"Gladdy","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0180","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1245\/s10434-015-4453-z","article-title":"Radiation-associated undifferentiated pleomorphic sarcoma is associated with worse clinical outcomes than Sporadic Lesions","volume":"22","author":"Dineen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.012_b0185","first-page":"1845","article-title":"Salvage surgery for head and neck squamous cell carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology","volume":"271","author":"Mandapathil","year":"2014","journal-title":"Head Neck Surg"},{"key":"10.1016\/j.radonc.2022.11.012_b0190","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.anl.2018.03.008","article-title":"Overcoming wound complications in head and neck salvage surgery","volume":"45","author":"Kwon","year":"2018","journal-title":"Auris Nasus Larynx"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:05Z","timestamp":1759123325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022045601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"alternative-id":["S0167814022045601"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.012","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-irradiation sarcoma after definitive radiation therapy for nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109423"}}